Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP-Reference-Cited by-同舟云学术

Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP

Published:2018-04-24 Issue:31 Volume:9 Page:22147-22157
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Supiot Stéphane¹,Campion Loic¹,Pommier Pascal²,Dore Mélanie¹,Palpacuer Clément¹,Racadot Séverine²,Rio Emmanuel¹,Milano Gérard A.³,Mahier - Ait Oukhatar Céline⁴,Carrie Christian²

Affiliation:

1. Departments of Radiation Oncology and Biostatistics, Institut de Cancérologie de l'Ouest, Nantes, France

2. Department of Radiation Oncology, Centre Léon Berard, Lyon, France

3. Laboratoire d’Oncopharmacologie, Centre Antoine-Lacassagne, Nice, France

4. Groupe des Essais Précoces, Unicancer, Paris, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial;European Urology Oncology;2024-05

2. Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU);Cancer Treatment Reviews;2023-11

3. Reply to RE: Should LHRH therapy be continued in patients receiving Abiraterone Acetate?;Prostate Cancer and Prostatic Diseases;2022-11-29

4. Should LHRH therapy be continued in patients receiving abiraterone acetate?;Prostate Cancer and Prostatic Diseases;2022-08-26

5. Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients;Frontiers in Oncology;2021-12-24